Steffanie Strathdee, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Adaptive Phage Therapeutics
    Topic:
    Phage Therapeutics
    Date added:
    12/13/2021
    Date updated:
    12/13/2021
Return to “The Enemy of My Enemy: The Story Behind the Center for Innovative Phage Applications & Therapeutics (IPATH)”

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.